In this Issue:
Safety of anagrelide in essential thrombocythaemia
Cardiovascular ischaemic events in dasatinib patients
Imatinib vs dasatinib in CML
Arsenic trioxide plus ATRA for APL
Ibrutinib vs ofatumumab in previously treated CLL
Ibrutinib in MCL: durable response and QOL linked
Idelalisib in double-refractory indolent B-cell NHL
Managing PNH in pregnancy with eculizumab
Pomalidomide in relapsed/ refractory multiple myeloma
Please login below to download this issue (PDF)